The Discounted Cash Flow (DCF) valuation of Gilead Sciences Inc (GILD) is 167.26 USD. With the latest stock price at 150.56 USD, the upside of Gilead Sciences Inc based on DCF is 11.1%.
Based on the latest price of 150.56 USD and our DCF valuation, Gilead Sciences Inc (GILD) is a buy. buying Gilead stocks now will result in a potential gain of 11.1%.
| Range | Selected | |
| WACC / Discount Rate | 5.7% - 7.7% | 6.7% |
| Long-term Growth Rate | 2.0% - 4.0% | 3.0% |
| Fair Price | 106.34 - 371.14 | 167.26 |
| Upside | -29.4% - 146.5% | 11.1% |